NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Reyon Pharm (KO: 102460)

 
102460 Technical Analysis
4
As on 26th Nov 2025 102460 STOCK Price closed @ 10880.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 11761.85 & Strong Sell for SHORT-TERM with Stoploss of 13087.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

102460STOCK Price

Open 10270.00 Change Price %
High 11030.00 1 Day 580.00 5.63
Low 10170.00 1 Week -200.00 -1.81
Close 10880.00 1 Month -320.00 -2.86
Volume 48108 1 Year -3270.00 -23.11
52 Week High 14150.00 | 52 Week Low 10050.00
 
KO Korea Most Active Stocks
093230 33.00 -49.23%
093230 33.00 -49.23%
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
005930 102800.00 3.52%
068330 1811.00 2.72%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
000650 140200.00 29.94%
000650 140200.00 29.94%
000650 140200.00 29.94%
168490 159.00 29.27%
168490 159.00 29.27%
152550 383.00 19.69%
152550 383.00 19.69%
009155 121800.00 13.94%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
093230 33.00 -49.23%
001745 3600.00 -46.27%
 
 
102460
Daily Charts
102460
Intraday Charts
Whats New @
Bazaartrend
102460
Free Analysis
 
102460 Important Levels Intraday
RESISTANCE12537.22
RESISTANCE12005.74
RESISTANCE11677.22
RESISTANCE11348.70
SUPPORT10411.30
SUPPORT10082.78
SUPPORT9754.26
SUPPORT9222.78
 
102460 Forecast November 2025
4th UP Forecast14637.7
3rd UP Forecast13432.5
2nd UP Forecast12687.7
1st UP Forecast11942.8
1st DOWN Forecast9817.25
2nd DOWN Forecast9072.35
3rd DOWN Forecast8327.45
4th DOWN Forecast7122.35
 
102460 Weekly Forecast
4th UP Forecast13866.85
3rd UP Forecast12908.95
2nd UP Forecast12316.85
1st UP Forecast11724.75
1st DOWN Forecast10035.25
2nd DOWN Forecast9443.15
3rd DOWN Forecast8851.05
4th DOWN Forecast7893.15
 
102460 Forecast2025
4th UP Forecast19744.2
3rd UP Forecast16901.4
2nd UP Forecast15144.2
1st UP Forecast13387
1st DOWN Forecast8373
2nd DOWN Forecast6615.8
3rd DOWN Forecast4858.6
4th DOWN Forecast2015.8
 
 
102460 Other Details
Segment EQ
Market Capital 1006583742464.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
102460 Address
102460
 
102460 Latest News
 
Your Comments and Response on Reyon Pharm
 
102460 Business Profile
REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea. Address: 416 Yeongdong-daero, Seoul, South Korea
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service